Patents by Inventor Ge Lin

Ge Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260327567
    Abstract: Provided are a cell culture product and the use thereof. The cell culture product comprises a hepatic progenitor cell proliferation medium, containing a DMEM/F12 medium, insulin, transferrin, sodium selenite, nicotinamide, 2-phosphate-L-ascorbic acid, a human recombinant albumin, an epidermal cell growth factor, a glycogen synthase kinase 3 inhibitor, a transforming growth factor ? receptor inhibitor, lysophosphatidic acid, and sphingosine phosphate.
    Type: Application
    Filed: June 26, 2023
    Publication date: October 22, 2026
    Inventors: Yi SUN, Ge LIN, Qi OUYANG, Guangxiu LU
  • Publication number: 20260297576
    Abstract: The present disclosure relates to the use of a nucleic acid molecule in preparation of a drug for treating a liver disease. The nucleic acid molecule satisfies one or more of the following conditions: including any one or more of miR-302s; including mimics or derivatives thereof; including a miRNA precursor which can be processed into any one or more of miR-302s and mimics or derivatives thereof, including a polynucleotide fragment which can be transcribed in a host to form a miRNA precursor; and including an expression vector.
    Type: Application
    Filed: June 26, 2023
    Publication date: October 1, 2026
    Inventors: Ge LIN, Yi SUN, Guangxiu LU, Jie LI
  • Publication number: 20260273991
    Abstract: Disclosed is a heat erasable eraser, including a housing (1); a heat erasing assembly (2), connected to the housing (1), where the heat erasing assembly (2) includes a heat erasing head (21); and a protective cover (3), movably connected to the housing (1) or the heat erasing assembly (2), where the protective cover (3) is operated to enable the heat erasing head (21) to be optionally exposed outside the protective cover (3) or covered by the protective cover (3). In the heat erasable eraser of this disclosure, by disposing the movable protective cover, the heat erasing head is exposed outside the housing when needed and covered by the protective cover when not needed, so that a user can be effectively prevented from being accidentally burnt by the heat erasing head, thereby improving the safety performance of the product.
    Type: Application
    Filed: January 14, 2026
    Publication date: September 17, 2026
    Applicant: Guangzhou Youxiang Cultural Supplies Co.,Ltd
    Inventors: Xiongliang XIAO, Ge LIN
  • Publication number: 20260113817
    Abstract: A microwave oven includes a housing defining a cooking cavity and a component cavity external to the cooking cavity and a heating plate fixedly supported within the cooking cavity on a lower surface thereof and including an electric heating element disposed on at least a portion of the heating plate and defining first and second electric contact elements on an underside thereof. A pair of conductive connection elements are mounted within the component cavity and extend through the lower surface of the cooking cavity to define respective ends of the conductive connection elements that are moveable with respect to the lower surface of the cooking cavity and are in contact with the first and second electric contact elements of the heating plate.
    Type: Application
    Filed: September 20, 2022
    Publication date: April 23, 2026
    Applicant: WHIRLPOOL CORPORATION
    Inventors: Ge Lin, Li Xin
  • Publication number: 20250392088
    Abstract: An electronic device has a housing with a device interface area. The device interface area includes an electrical connector operatively coupled to the housing, where the first electrical connector includes a first casing that supports blade-style electrical contacts and includes a resilient member that forms a sleeve around the first casing such that the first casing nests within the resilient member. The resilient member is disposed between the casing and the housing. The casing is configured to be movable relative to the housing by reversibly deforming the resilient member.
    Type: Application
    Filed: July 31, 2024
    Publication date: December 25, 2025
    Inventors: Li-Ko Wang, Ge Lin, Zhiming Zhang, Yanmin Mao
  • Publication number: 20210366122
    Abstract: Provided are a method and an apparatus for segmenting a G-banded adhered chromosome based on a geometrical characteristic and regional fusion, and a chromosome karyotype analysis device. The method first extracts concave points of an outline of an adhered chromosome region, then cuts an adhered chromosome image via a cutting line formed by the concave points in pairs, and at last carries out a fusion operation on a local cut region and selects a most appropriate region as a final single chromosome region. The method implements automatic segmentation of an adhered chromosome and improves the chromosome karyotype analysis efficiency.
    Type: Application
    Filed: October 22, 2018
    Publication date: November 25, 2021
    Inventors: Shengri FENG, Ge LIN, Yi LI, Guangxiu LU, Yang MU, Yueqiu TAN, Yufeng CAI, Zixing CAI
  • Patent number: 9308222
    Abstract: The present invention provides formulas of elemental compositions encompassing acetate salts of calcium, magnesium and zinc along with vitamin D3. The acetate salts could be extracted from natural sources such as pearls, coral, and oyster or compounded using synthetic materials. The dosage and ratio of calcium to magnesium was estimated using in vitro and in vivo estimations. The dosage for promoting bone health and alleviation of osteoporosis is about a quarter to a third of the conventional dose.
    Type: Grant
    Filed: July 28, 2010
    Date of Patent: April 12, 2016
    Inventors: Yun Kau Tam, Ge Lin
  • Patent number: 9056916
    Abstract: An antibody, which specifically recognizes adducts between pyrrole and cellular macromolecules. Such adducts are likely to occur in mammals suffering an incident of pyrrolizidine alkaloid poisoning. The antibody can be produced using a synthetic immunogen conjugated with a pyrrole as a hapten and it can be used, for example in an assay kit and/or by itself, as a novel means for detecting or diagnosing pyrrolizidine alkaloid poisoning both clinics and research laboratories.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: June 16, 2015
    Assignee: THE CHINESE UNIVERSITY OF HONG KONG
    Inventors: Ge Lin, Jiang Zheng, Na Li
  • Publication number: 20130189710
    Abstract: An antibody, which specifically recognizes adducts between pyrrole and cellular macromolecules. Such adducts are likely to occur in mammals suffering an incident of pyrrolizidine alkaloid poisoning. The antibody can be produced using a synthetic immunogen conjugated with a pyrrole as a hapten and it can be used, for example in an assay kit and/or by itself, as a novel means for detecting or diagnosing pyrrolizidine alkaloid poisoning both clinics and research laboratories.
    Type: Application
    Filed: January 20, 2012
    Publication date: July 25, 2013
    Inventors: Ge Lin, Jiang Zheng, Na Li
  • Publication number: 20110312923
    Abstract: The present invention provides formulas of elemental compositions encompassing acetate salts of calcium, magnesium and zinc along with vitamin D3. The acetate salts could be extracted from natural sources such as pearls, coral, and oyster or compounded using synthetic materials. The dosage and ratio of calcium to magnesium was estimated using in vitro and in vivo estimations. The dosage for promoting bone health and alleviation of osteoporosis is about a quarter to a third of the conventional dose.
    Type: Application
    Filed: July 28, 2011
    Publication date: December 22, 2011
    Inventors: Yun Kau TAM, Ge LIN
  • Publication number: 20100292194
    Abstract: The present invention provides formulas of elemental compositions encompassing acetate salts of calcium, magnesium and zinc along with vitamin D3. The acetate salts could be extracted from natural sources such as pearls, coral, and oyster or compounded using synthetic materials. The dosage and ratio of calcium to magnesium was estimated using in vitro and in vivo estimations. The dosage for promoting bone health and alleviation of osteoporosis is about a quarter to a third of the conventional dose.
    Type: Application
    Filed: July 28, 2010
    Publication date: November 18, 2010
    Applicant: SINOVEDA CANADA, INC.
    Inventors: Yun Kau TAM, Ge LIN
  • Patent number: 6992078
    Abstract: The present invention provides plant extracts, isolated alkaloids, synthetic alkaloids and compositions having antitussive activity. In some preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of a genus in the family Stemonaceae. In other preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of the genus Stemona, Croomia, or Stichoneuron. In especially preferred embodiments, the plant extracts and the isolated alkaloids are from the plant Stemona tuberosa. The present invention further provides methods for isolating such plant extracts and alkaloids. In addition, the present invention provides methods for reducing or suppressing coughing by administering plant extracts, alkaloids and compositions having antitussive activity.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: January 31, 2006
    Assignee: The Chinese University of Hong Kong
    Inventors: Ge Lin, Hoi Sing Chung, Po Ming Hon, Hui Dong, Paul P. H. But
  • Publication number: 20050256101
    Abstract: The present invention provides plant extracts, isolated alkaloids, synthetic alkaloids and compositions having antitussive activity. In some preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of a genus in the family Stemonaceae. In other preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of the genus Stemona, Croomia, or Stichoneuron. In especially preferred embodiments, the plant extracts and the isolated alkaloids are from the plant Stemona tuberosa. The present invention further provides methods for isolating such plant extracts and alkaloids. In addition, the present invention provides methods for reducing or suppressing coughing by administering plant extracts, alkaloids and compositions having antitussive activity.
    Type: Application
    Filed: July 19, 2005
    Publication date: November 17, 2005
    Applicant: The Chinese University of Hong Kong
    Inventors: Ge Lin, Hoi Chung, Po Hon, Hui Dong, Paul But
  • Publication number: 20030229071
    Abstract: The present invention provides plant extracts, isolated alkaloids, synthetic alkaloids and compositions having antitussive activity. In some preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of a genus in the family Stemonaceae. In other preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of the genus Stemona, Croomia, or Stichoneuron. In especially preferred embodiments, the plant extracts and the isolated alkaloids are from the plant Stemona tuberosa. The present invention further provides methods for isolating such plant extracts and alkaloids. In addition, the present invention provides methods for reducing or suppressing coughing by administering plant extracts, alkaloids and compositions having antitussive activity.
    Type: Application
    Filed: April 24, 2002
    Publication date: December 11, 2003
    Applicant: The Chinese University of Hong Kong
    Inventors: Ge Lin, Hoi Sing Chung, Po Ming Hon, Hui Dong, Paul P.H. But